These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18275497)

  • 1. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
    Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis.
    Ishizaki M; Matsunaga T; Adachi K; Miyashita E
    Hemodial Int; 2004 Jul; 8(3):219-25. PubMed ID: 19379421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinase-3 in systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Arch Dermatol Res; 2004 Jun; 296(1):25-9. PubMed ID: 15095096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circulating beta 2-microglobulin intermediate in hemodialysis patients.
    Uji Y; Motomiya Y; Ando Y
    Nephron Clin Pract; 2009; 111(3):c173-81. PubMed ID: 19194107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
    Fry AC; Singh DK; Chandna SM; Farrington K
    Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients.
    Tsukahara S; Shinozaki M; Ikari K; Mochizuki T; Inoue E; Tomatsu T; Hara M; Yamanaka H; Kamatani N; Momohara S
    Rheumatology (Oxford); 2008 Jan; 47(1):41-4. PubMed ID: 18077489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
    Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
    Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
    Schiffl H
    Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and cellular interleukin-6 in haemodialysis patients: relationship with energy expenditure.
    Kamimura MA; Draibe SA; Dalboni MA; Cendoroglo M; Avesani CM; Manfredi SR; Canziani ME; Cuppari L
    Nephrol Dial Transplant; 2007 Mar; 22(3):839-44. PubMed ID: 17205966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8)].
    Hamakawa H; Takemura M; Sato M; Shinohe R; Koishi H; Furuta N; Ohta H; Koike N; Iwamoto N; Yamada Y; Wada H; Saito K; Seishima M
    Rinsho Byori; 2003 Jan; 51(1):13-8. PubMed ID: 12652686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.